Printer Friendly PDF U.S. Population is Aging According to the US Census Bureau, the US population aged 65+ years is expected to nearly double over thenext 30 years, from 43.1 million in 2012 to an estimated 83.7 million in 2050. These demographic advances, however...
Printer Friendly PDF Appropriate Medication Administration Appropriate medication administration pass times are critical to the success of your patients’ medication regimen! In general, routine medication regimens should be administered at consistent times from day to...
Printer Friendly PDF What is Tardive Dyskinesia (TD)? Tardive Dyskinesia (TD) is a drug-induced involuntary movement disorder (DIMD) generally of the tongue, lower face, jaw, and extremities (but sometimes also pharyngeal, diaphragmatic, and trunk muscles) that can...
Printer Friendly PDF From the Centers for Medicare & Medicaid Services (CMS) From CMS: §483.45(g) Labeling of Drugs and Biologicals and §483.45(h) Storage of Drugs and Biologicals: “ensure that all drugs and biologicals used in the facility are labeled in...
Printer Friendly PDF What is Pharmacogenomics (PGx) testing? PGx is rapidly evolving science focused on how an individual’s genes may affect his or her response to medications. While many patients may metabolize a medication appropriately, others may metabolize it too...
Printer Friendly PDF What are GLP-1 Receptor Agonists (GLP-1 RA)? The GLP-1 Receptor Agonist (GLP-1 RA) medications, also referred to as incretin mimetics or GLP-1 analogs, are biochemical variations of naturally occurring GLP-1 altered for enhanced potency and...
Printer Friendly PDF What are Anticholinergic Drugs? Anticholinergic medications (‘anticholinergics’) are drugs that block and inhibit the activity of the neurotransmitter acetylcholine found in the central and peripheral nervous system. In doing so, these drugs...
Printer Friendly PDF What is a Continuous Glucose Monitor (CGM)? A CGM is a wearable device that as the name implies, continually monitors your interstitial blood glucose (sugar) level providing real-time data to inform diabetes management. With expanded access,...
Printer Friendly PDF Common Fall & Winter Respiratory Illnesses Circulating respiratory viruses such as COVID-19, influenza (flu) and respiratory syncytial virus (RSV) aremore common in fall and winter, and can lead to significant illness and disease. COVID-19,...
Printer Friendly PDF Addressing Polypharmacy Polypharmacy, the concurrent use of multiple medications by a single individual, is a common and concerning issue among older adult patients. As we age, the risk for developing chronic health conditions becomes more common,...
Printer Friendly PDF FDA Approves First RSV Vaccines In May 2023, the Food and Drug Administration (FDA) approved the first vaccines for prevention of RSV associated lower respiratory tract disease (LRTD) in adults aged ≥60 years. RSVPreF3 (Arexvy, GSK) is a 1-dose...
Printer Friendly PDF Certain inhalation devices once opened or assembled and in use, must be used within a specified timeframe to avoid reduced stability and sterility, which can impact efficacy of treatment. Medications with shortened expiration dates, as specified...